PT -期刊文章盟科拉Ormseth AU -圭多要求盟莎拉Jasak AU -大卫Mampre盟奥黛丽现有非盟-劳拉Miyares Michael James AU -大卫·黄盟盟-费尔南多Testai盟凯拉•贝克尔AU -大卫Tirschwell AU -卡尔Langefeld盟-丹尼尔·吴盟凯文Sheth TI -种族差异在安慰措施只有在脑出血患者(S42.008) DP - 2018年4月10 TA -神经病学PG - S42.008 VI - 90 IP - 15补充4099 - //www.ez-admanager.com/content/90/15_Supplement/S42.008.short 4100 - //www.ez-admanager.com/content/90/15_Supplement/S42.008.full所以Neurology2018 4月10;首页90 AB -目的:我们试图确定安慰措施只有地位的决定因素(CMOs)在大型多中心和多民族颅内出血的队列研究(我)。背景:以往的研究各种危重患者的诊断发现,非白种人追求CMOs的可能性更小。这种潜在的民族/种族差异有重要意义对临终关怀的质量。设计/方法:我们分析了我的情况下,从2010年到2015年就读民族/种族差异颅内出血(ERICH)的研究中,基于多中心研究在美国。临床、人口和放射非创伤性颅内出血患者前瞻性收集的数据。单变量和多变量逻辑回归是用来评估之间的联系民族/种族和CMOs调整了潜在的混杂因素。包括在这项研究结果:2705我例(平均年龄62(14),女性1119 [41%])。188金宝慱官网下载其中,912年是黑人(34%),893年西班牙900年(33%)和白人(33%)。CMOs病人由276(10%)、64(7%)、79年(9%)和133年(15%)的整个队列和黑人,西班牙裔和白人群体,分别(术中,0.001)。在多变量分析调整年龄、发病前的状况和临床严重程度,黑人患者的一半可能白人患者CMO地(或0.50,95%可信区间0.34 - -0.75;p = 0.001),这一趋势对拉美裔患者不太可能CMOs白人患者相比(或0.72,95%可信区间0.49 - -1.06,p = 0.093)。 Other factors associated with the use of CMOs included age (p<0.001), premorbid modified Rankin Scale (p<0.001), dementia (p=0.008), admission Glasgow Coma Scale (p=0.009), hematoma volume (p<0.001), intraventricular hematoma volume (p<0.001), lobar (p=0.032) and brainstem (p<0.001) bleeds and intubation (p<0.001).Conclusions: Black patients were less likely than white patients to be made CMO after controlling for potential confounders. Further investigation is warranted to better understand the causes and implications of racial disparities in ICH CMO decisions.Study Supported by:This study was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS: U-01-NS069763). This report does not represent the official view of NINDS, the National Institutes of Health (NIH), or any part of the US Federal Government. No official support or endorsement of this article by NINDS or NIH is intended or should be inferred.Disclosure: Dr. Ormseth has nothing to disclose. Dr Falcone has nothing to disclose. Dr. Jasak has nothing to disclose. Dr. Mampre has nothing to disclose. Dr. Leasure has nothing to disclose. Dr. Miyares has nothing to disclose. Dr. Hwang has nothing to disclose. Dr. James has nothing to disclose. Dr Testai has nothing to disclose. Dr. Becker has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with ICON. Dr. Tirschwell has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbot. Dr. Langefeld has nothing to disclose. Dr. Woo has nothing to disclose. Dr. Sheth has nothing to disclose.